Clinical Pharmacokinetics of the Antiandrogens and Their Efficacy in Prostate Cancer

ISSN： 0312-5963

Source： Clinical Pharmacokinetics, Vol.34, Iss.5, 1998-05, pp. : 405-417

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Perspectives on designs of antiandrogens for prostate cancer

By EstÉbanez-PerpiñÁ Eva Jouravel Natalia Fletterick Robert J

Expert Opinion on Drug Discovery, Vol. 2, Iss. 10, 2007-10 ,pp. : 1341-1355

Informa Healthcare

Access to resources Recommend Favorite

Tolerability of Antiandrogens in the Treatment of Prostate Cancer

By Fourcade R.-O. McLeod D.

UroOncology, Vol. 4, Iss. 1, 2004-03 ,pp. : 5-13

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Antiandrogens in Prostate Cancer Endocrine Therapy

Current Cancer Drug Targets, Vol. 4, Iss. 5, 2004-08 ,pp. : 455-461

Bentham Science Publishers

Access to resources Recommend Favorite

Do antiandrogens improve survival in prostate cancer?

Inpharma, Vol. 1, Iss. 1236, 2000-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Non-steroidal anti-androgens in prostate cancer - current treatment practice

By Han M. Nelson J.B.

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 3, 2000-03 ,pp. : 443-449

Informa Healthcare

Access to resources Recommend Favorite